The automatic ownership maintenance feature is a structural anti-dilution mechanism for insiders that will continuously dilute public shareholders as the company issues more equity to raise capital. Watch for the vote outcome on November 20 — if approved, expect accelerated equity issuance and further dilution. The company's need to raise capital and maintain its NYSE listing creates a self-reinforcing dilution cycle.
Price Chart
Executive Summary
Endovia Health Sciences is seeking stockholder approval at its November 20, 2026 annual meeting for a highly dilutive equity plan amendment and RSU grants that would award insiders 20% of the company's fully diluted shares (approximately 4,029,561 shares) through an automatic ownership maintenance feature. The company has been suffering significant losses and negative cash flow, recently settled a $2.8M debt for $301,801, and faces NYSE American listing compliance issues including a stockholders' equity deficiency notice. The proxy also discloses a net loss of -$25.2 million for 2025 and a cumulative TSR of $0.35 per $100 invested since listing, indicating severe value destruction.
Key Facts
- Proposal 4 seeks to increase shares authorized under the 2025 Plan by 4,815,780 shares and add an automatic ownership maintenance feature to maintain insider ownership at 20% of fully diluted shares
- Proposal 5 seeks approval of RSU grants totaling 20% of fully diluted shares (~4,029,561 shares) to eight covered persons, with Brady Cobb and Michael Bondurant each receiving 7% (1,428,546 shares)
- Net loss was -$25.2 million in 2025, -$23.8 million in 2024, and -$21.0 million in 2023
- Cumulative TSR: a $100 investment at listing is now worth $0.35 as of year-end 2025
- Company settled a $2,834,689 debt with Decathlon Alpha IV for $301,801 in July 2026
- Company received a NYSE American stockholders' equity deficiency notice and is pursuing strategic alternatives including a potential merger or acquisition
- Former CEO Robert Nistico received total compensation of $1,610,477 in 2025 (SCT) while the company lost -$25.2 million
- All four director nominees are incumbents; no contested election or shareholder proposals on the ballot
- No say-on-pay vote results from prior year are disclosed in the filing
Financial Impact
The proposed RSU grants represent 20% of fully diluted shares (~4,029,561 shares), which would massively dilute existing common stockholders. The company reported net losses of -$25.2M (2025), -$23.8M (2024), and -$21.0M (2023). A $100 investment at listing is now worth $0.35.
Risk Factors
- Massive dilution to existing shareholders if Proposals 4 and 5 pass — insiders would receive 20% of fully diluted shares with automatic maintenance
- Company has negative cash flow and must continue issuing equity-linked securities to fund operations, creating ongoing dilution
- NYSE American delisting risk due to stockholders' equity deficiency
- Related party debt disputes with former CEO Robert Nistico ($400,000 in advances plus disputed interest) and outstanding merchant cash advances totaling ~$742,751
- Compensation is not aligned with performance — former CEO received $1.6M in 2025 while company lost -$25.2M
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001731122-26-001316 |
| Document: 0001731122-26-001316-index-headers.html | 0001731122-26-001316 |
| Document: 0001731122-26-001316-index.html | 0001731122-26-001316 |
| Document: 0001731122-26-001316.txt | 0001731122-26-001316 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | S-1 | $0.1613 | awaiting T+1 | — | $0.1651 (−2.36%) |
Oct 27, 2026 today | 8-K | $0.1651 | awaiting T+1 | — | $0.1651 (+0.00%) |
Oct 22, 2026 5d ago | SC 13G | $0.1600 $0.1577 | ▼ −1.44% | ▼ −2.15% | $0.1651 (+3.19%) |
Oct 15, 2026 12d ago | 8-K | $0.1460 $0.1350 | ▲ +7.53% | ▲ +7.96% | $0.1651 (−13.08%) |
Oct 6, 2026 21d ago | 8-K | $0.1650 $0.1599 | ▲ +3.09% | ▲ +2.67% | $0.1651 (−0.06%) |
Oct 5, 2026 22d ago | DEF 14A | $0.1679 $0.1650 | ▲ +1.73% | ▲ +1.49% | $0.1651 (+1.67%) |
Oct 5, 2026 22d ago | 8-K | $0.1680 $0.1650 | ▼ −1.79% | ▼ −1.55% | $0.1651 (−1.73%) |
Aug 31, 2026 8w ago | 8-K | $0.2954 $0.2614 | ▼ −11.51% | ▼ −11.95% | $0.1651 (−44.11%) |
Aug 25, 2026 9w ago | EFFECT | $0.4182 $0.3650 | ▲ +12.72% | ▲ +12.74% | $0.1651 (+60.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers